Postoperative radiotherapy improves disease-free survival of EGFR wild-type pN2 non-squamous-cell non-small-cell lung cancer (Nsq-NSCLC) patients after complete resection: a propensity score matching analysis

Abstract Background The ADAURA study indicated that adjuvant TKI therapy improves survival in postoperative patients with EGFR-mutated (EGFRm) non-small-cell lung cancer (NSCLC), especially in stage III disease. However, the effect of PORT for stage III (N2) NSCLC with different EGFR statuses remain...

Full description

Bibliographic Details

Published in:	Radiation Oncology
Main Authors:	Yunsong Liu, Yu Men, Xu Yang, Shuang Sun, Yongxing Bao, Zeliang Ma, Yang Wang, Yirui Zhai, Jianyang Wang, Lei Deng, Wenqing Wang, Nan Bi, Luhua Wang, Zhouguang Hui
Format:	Article
Language:	English
Published:	BMC 2025-03-01
Subjects:	Postoperative radiotherapy Non-squamous-cell non-small-cell lung cancer EGFR Survival
Online Access:	https://doi.org/10.1186/s13014-025-02592-0